Article
Structural basis for ADAM17 activation by the iRhom1 pseudoprotease.
Cell reports - 26 May 2026
Ungvary Joseph N, Maciag Joseph J, Alnajjar Hala F, Dávila Eliud Morales, Slone Conner E, Thomas Joel E, Rich Maria F, Carazo Sophia A, Ifergan Igal, Perez-Aguilar Jose Manuel, Blobel Carl P, Seegar Tom C M
Abstract excerpt
The a disintegrin and metalloproteinase (ADAM)-17 releases pro-inflammatory cytokines, including tumor necrosis factor-α, and several epidermal growth factor receptor ligands from cells. ADAM17 is post-translationally regulated by the inactive rhomboid pseudoproteases iRhom1 and iRhom2, and dysregulation of this signaling axis contributes to diseases ranging from chronic inflammation to cancer. Here, we present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
